In the present study, we evaluated VEGF and suPAR levels as candidates for non-invasive biomarkers of disease activity in LN and assessed their association with traditional laboratory tests used to monitor disease activity in SLE and LN. This evidence concerns the gene VEGFA and lobular neoplasia.